OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
July 23, 2008
After years of owning a majority share in Genentech, Roche makes a play to buy out the rest of the biotech firm.
Bristol-Meyers Squibb will pay more than half a billion dollars to settle charges that it illegally promoted the sale of the anti-psychotic drug Abilify for off-label uses.